Tinnitus—the perception of sound without an external source—affects millions of people worldwide and can be a deeply frustrating condition. Columbia Basin Hearing Center is proud to offer Lenire, an innovative, FDA-approved tinnitus treatment that uses a unique bimodal neuromodulation approach to help reduce tinnitus symptoms.

Lenire has been recommended by 83% of patients who have completed treatment and has demonstrated high efficacy across three large FDA-reviewed clinical trials. These studies show meaningful, clinically significant improvements for a majority of patients, offering real hope where few effective options previously existed.

To learn more about the science behind Lenire and review the clinical trial data, click here.

WHAT IS LENIRE?

Lenire uses a combination of sound therapy delivered through Bluetooth headphones and a tongue-tip stimulator to provide gentle electrical stimulation. Together, this simultaneous stimulation alters or reduces tinnitus pathways over time.

Safe

Lenire is the only bimodal neuromodulation device with FDA approval following a controlled trial. In recent studies, nearly 80% of participants experienced a meaningful reduction in tinnitus severity.

Customized

Treatment with Lenire is tailored for each individual. Columbia Basin Hearing Center's audiologists will guide you every step of the way, ensuring you get the best results.

Lenire is the only bimodal neuromodulation device with FDA approval following a controlled trial. In recent studies, nearly 80% of participants experienced a meaningful reduction in tinnitus severity.